Publications

2013:

Patent Landscape Report for Pegylated Interferon Alfa 2A & 2B, February 2013

2012:

Secondary Patenting of Branded Pharmaceuticals: A Case Study of How Patents on Two HIV Drugs Could Be Extended for Decades, Tahir Amin and Aaron Kesselheim, Health Affairs, October 2012 [Summary available here]

Voluntary Licensing: Optimizing Global Efforts and Measuring Impact, I-MAK/ITPC, 10 September 2012 [French][Spanish][Russian]

Challenges to India's Pharmaceutical Patent Laws, Science Policy Forum, July 29 2012, Data Supplement to article available here.

2011:

Evaluating the Potential Impact of Aurobindo's Unbundling, December 2011

Granted Pharmaceutical Patents in Egypt, December 2011

Financial Impact of the Medicines Patent Pool: I-MAK/ITPC Counter Analysis, October 2011 (This report supplements Measuring the Impact of Medicines Patent Pool Licenses: A Civil Society Assessment)

Briefing Paper: Analysis of the Patent Pool Licenses (Spanish Version - pdf), 25 July 2011

Briefing Memo: Risks of the Trans-Pacific Free Trade Agreement for Access to Medicines - Analysis of the Leaked U.S. Paper Eliminating Patent Pre-Grant Opposition, 7 July 2011

Opinion: Patent Reform Must Emphasize Quality Advances and Citizen Review, Mercury News, 16 May 2011

EU Pharma Trade Hoax, Hindu BusinessLine, 25 February 2011 (html)(pdf)

Don't Swallow This Pill, Indian Express, 27 January 2011 (html as published)(pdf original)

2010:

Searching for Transparency: Improving Patent Information to Increase Access to Medicines, Tahir Amin, Bridges, November-December 2010 [pdf]

How to Conduct Patent Searches for Medicines - A Step by Step Guide, Tahir Amin, World Health Organization, South East Asia Region and Western Pacific Region, 2010 [pdf]

Intellectual Property, technology transfer and manufacture of low-cost HPV vaccines in India, Swathi Padmanabhan, Tahir Amin, Bhaven Sampat, Robert Cook-Deegan and Subhashini Chandrasekharan, Nature Biotechnology, July 2010. [pdf]

HIV Drug Patents in China - A Patent Landscape, Tahir Amin, Initiative for Medicines, Access & Knowledge, May 2010 [pdf]

When Medical Patents Weaken Health Care, Tahir Amin and Priti Radhakrishnan, Huffington Post, April 1 2010

2009:

Expert Review of Drug Patent Applications: Improving Health in the Developing World, Tahir Amin, Rahul Rajkumar, Priti Radhakrishnan and Aaron kesselheim, Health Affairs, 25 August 2009 [PDF]

2008:

Access to anti-retrovirals (ARVs) in india: Patents and the way forward, Infochange, September 2008 [pdf]

2007:

La impugnación de patentes: protección del dominio público y acceso a medicamentos asequibles", Archipiélago, Cuadernos de Crítica de la Cultura. nº 77-78, Noviembre 2007, pp. 73-77. (The Patent Challenge: Protecting the Public Domain and Access to Medicines, Archipielago Journal, November 2007) (PDF-Spanish)(PDF- English)

Urgent Need for Second-Line HIV Treatment, Radhakrishnan and Abraham, Indian Medical Parliamentarians Forum, February-May 2007 (PDF)

India and Second-Line ART, Evaluating the Way Forward, INP+ Discussion Paper, March 2007 (PDF)

India's Patent Act On Trial, Bridges, February - March 2007 (PDF)

Voluntary Licensing Practices in the Pharmaceutical Sector: An Acceptable Solution to Improving Access to Affordable Medicines?, Oxfam GB, February 2007 (PDF)

2006:

Pre-Grant Patent Opinions in Vietnam and Their Role in Access to Medicines: A Brief Practical Guide, Oxfam, November 2006 (PDF)

Data Exclusivity - The Impact of Article 39.3 in India: A Practical Perspective, I-MAK, July 2006 (PDF)
(available at the NYU Institute for International Law and Justice, South Asia Dialogue Series, and cited in the Government of India Article 39.3 Report)

Taming of the Flu: Working Through The Tamiflu Patents in India, Shamnad Basheer and Tahir Amin, Journal of Intellectual Property Rights, March 2006 (PDF)

2005:

Implications of India's New Patent Law, Bridges, April 2005 (Link) (PDF)

Patents (Amendment) Bill 2005: A Critique, Gopakumar and Amin, Economic and Political Weekly, April 2005 (PDF)